Pharminent

AstraZeneca offloads more non-core assets

The British drugmaker has worked to trim its portfolio, selling off older drugs to help offset revenue declines from key products. http://www.biopharmadive.com/news/astrazeneca-offloads-more-non-core-assets/443315/

Filed under: Company